Use of telomerase Inhibitors for the treatment of myeloproliferative disorders and myeloproliferative Neoplasms.

摘要

p This document provides meacute; all to reduce the proliferation of neoplastic progenitor cells and alleviate associated symptoms in individuals diagnosed with MPN or MDS or believed to have myeloproliferative disorders,such as essential thrombocytopenia (ET). In this case we also provide all paranbsp; use lanbsp inhibitors; telomerase paranbsp; maintain blood platelet counts at relatively normal intervals in lanbsp; blood from individuals diagnosed or suspected to have myeloproliferative disorders, such as ET. /p